Total Payments
$11,407
2024 Payments
$2,315
Companies
43
Transactions
690
Medicare Patients
2,595
Medicare Billing
$351,502
Payment Breakdown by Category
Food & Beverage$10,162 (89.1%)
Travel$794.87 (7.0%)
Education$250.00 (2.2%)
Other$200.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,162 | 683 | 89.1% |
| Travel and Lodging | $794.87 | 3 | 7.0% |
| Education | $250.00 | 3 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,861 | 300 | $0 (2024) |
| Boston Scientific Corporation | $1,416 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,114 | 83 | $0 (2024) |
| Janssen Biotech, Inc. | $820.66 | 46 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $808.45 | 54 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $300.32 | 12 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $259.07 | 16 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $257.94 | 20 | $0 (2017) |
| Gilead Sciences, Inc. | $246.42 | 15 | $0 (2024) |
| Shire North American Group Inc | $245.21 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,315 | 111 | ABBVIE INC. ($617.47) |
| 2023 | $1,371 | 95 | ABBVIE INC. ($570.06) |
| 2022 | $1,522 | 96 | ABBVIE INC. ($590.77) |
| 2021 | $896.02 | 77 | AbbVie Inc. ($343.98) |
| 2020 | $764.30 | 46 | AbbVie Inc. ($292.13) |
| 2019 | $991.76 | 66 | AbbVie, Inc. ($369.70) |
| 2018 | $1,532 | 90 | AbbVie, Inc. ($500.74) |
| 2017 | $2,014 | 109 | AbbVie, Inc. ($575.89) |
All Payment Transactions
690 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.90 | General |
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $1.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $0.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Immunology | ||||||
| 10/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: LIVER DISEASE | ||||||
| 10/01/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.29 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | Boston Scientific Corporation | Acquire (Device) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Acquire_ENDO | ||||||
| 09/16/2024 | Boston Scientific Corporation | Acquire (Device) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Acquire_ENDO | ||||||
| 09/16/2024 | Boston Scientific Corporation | Acquire (Device) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Acquire_ENDO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 517 | 631 | $417,148 | $59,129 |
| 2022 | 16 | 646 | 796 | $279,260 | $72,904 |
| 2021 | 23 | 690 | 881 | $462,674 | $111,177 |
| 2020 | 20 | 742 | 863 | $500,605 | $108,291 |
Total Patients
2,595
Total Services
3,171
Medicare Billing
$351,502
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 36 | 36 | $50,334 | $7,112 | 14.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 115 | $27,255 | $6,927 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 95 | $22,188 | $6,129 | 27.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 63 | 64 | $93,690 | $6,102 | 6.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 82 | 84 | $96,058 | $5,675 | 5.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 56 | $25,480 | $5,613 | 22.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 14 | 14 | $24,678 | $4,922 | 19.9% |
| 43276 | Replacement of stent in pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 11 | 14 | $22,938 | $4,881 | 21.3% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $15,090 | $2,567 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 26 | $9,242 | $2,400 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $8,950 | $1,996 | 22.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 17 | $5,848 | $1,558 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,962 | $1,267 | 21.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 27 | $3,480 | $1,024 | 29.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $2,925 | $507.43 | 17.3% |
| 74330 | Review by radiologist of image from tube placement into bile and pancreatic duct using an endoscope | Facility | 2023 | 16 | 21 | $3,030 | $448.14 | 14.8% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 22 | 27 | $29,295 | $9,224 | 31.5% |
| 43276 | Replacement of stent in pancreatic or bile duct using a flexible endoscope | Facility | 2022 | 18 | 27 | $30,375 | $8,934 | 29.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 76 | 77 | $18,310 | $7,977 | 43.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 75 | $54,750 | $7,946 | 14.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 36 | 37 | $34,225 | $7,511 | 21.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 84 | 89 | $46,725 | $6,872 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 99 | $12,110 | $6,333 | 52.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 62 | 117 | $9,360 | $3,585 | 38.3% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $9,775 | $2,596 | 26.6% |
About Dr. Mark Lybik, MD
Dr. Mark Lybik, MD is a Gastroenterology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184626707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Lybik, MD has received a total of $11,407 in payments from pharmaceutical and medical device companies, with $2,315 received in 2024. These payments were reported across 690 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,162).
As a Medicare-enrolled provider, Lybik has provided services to 2,595 Medicare beneficiaries, totaling 3,171 services with total Medicare billing of $351,502. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Indianapolis, IN
- Active Since 08/12/2005
- Last Updated 02/03/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1184626707
Products in Payments
- RINVOQ (Biological) $843.90
- Humira (Biological) $843.56
- Entyvio (Biological) $711.01
- XIFAXAN (Drug) $635.33
- STELARA (Biological) $607.45
- HUMIRA (Biological) $565.67
- DUPIXENT (Biological) $434.18
- EXPECT (Device) $356.14
- Creon (Drug) $303.34
- LINZESS (Drug) $281.06
- ENTYVIO (Biological) $272.29
- MAVYRET (Drug) $229.48
- VIBERZI (Drug) $181.27
- ZENPEP (Drug) $176.45
- SKYRIZI (Biological) $172.21
- REMICADE (Biological) $172.06
- ZEPOSIA (Drug) $169.46
- Mavyret (Drug) $167.23
- CREON (Drug) $149.40
- EXALT Model D (Device) $148.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Indianapolis
Douglas Rex, M.d, M.D
Gastroenterology — Payments: $785,487
Gastroenterology $785,487
Ajay Jain, Md, MD
Gastroenterology — Payments: $435,795
Gastroenterology $435,795
Dr. David Pound, M.d, M.D
Gastroenterology — Payments: $207,527
Gastroenterology $207,527
Raj Vuppalanchi, M.d, M.D
Gastroenterology — Payments: $183,853
Gastroenterology $183,853
Thomas Imperiale, M.d, M.D
Gastroenterology — Payments: $154,570
Gastroenterology $154,570
Glen Lehman, M.d, M.D
Gastroenterology — Payments: $98,291
Gastroenterology $98,291